BIIB059 Safe and Effective in Reducing CLE Activity Regardless of SLE
The efficacy of BIIBO59 in patients with cutaneous lupus erythematosus with and without concomitant systemic lupus erythematosus during 16 weeks was evaluated.
All articles by Dermatology Advisor Contributing Writer
Hidradenitis Suppurativa Associated With Increased Stroke Risk
The association between HS and strokes was assessed via a systematic review and meta-analysis.
Ruxolitinib Cream a Promising Option for Long-Term Vitiligo Treatment
The safety and efficacy of ruxolitinib cream following 104 weeks of treatment in a phase 2 study of adults is reported.
Baricitinib Shows Therapeutic Potential in Early- to Late-Onset Alopecia Areata
Baseline characteristics and treatment outcomes of patients with early-onset and late-onset alopecia areata are evaluated.
Procedure May Restore Stevens-Johnson Affected Eyes
Researchers show how COMET procedure can restore ocular surface anatomy and revive visual performance.
FDG-PET Superior to CT for Predicting Melanoma Relapse After Immunotherapy
The long-term outcome of patients with melanoma may be predicted by FDG-PET imaging and also influence treatment duration.
PET, CT Scans for the Staging of Malignant Melanoma
Findings suggest that PET/CT imaging should be included in the malignant melanoma treatment algorithm starting with T2 patients.
Immunotherapy Is a Viable Treatment Strategy for Advanced MCC and CSCC
The frequent and durable responses to PD-1/PD-L1–blocking antibodies confirm the importance of immune mechanisms in nonmelanoma skin cancer pathogenesis.
Video-Based Assessment May Improve Dermatology Resident Surgical Skills
The applicability of video-based assessment in providing dermatology residents with feedback on surgical technical skills and unsafe surgical practices is assessed.
Ixekizumab Superior to Secukinumab in Providing More Quality-Adjusted Life-Years in Psoriatic Arthritis
Researchers conducted cost-effectiveness analyses to compare ixekizumab and secukinumab in psoriatic arthritis and moderate to severe plaque psoriasis.
- Loading...
Loading...
Next post in Psoriasis
Loading... 
Loading...